Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Benelux

Benelux

Revenue in the Diabetes Care Devices market market in Benelux is projected to reach US$0.48bn in 2024.
Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 11.84%, which will lead to a market volume of US$0.84bn by 2029.
In a global context, the majority of revenue will be generated the United States, with a figure of US$11,710.00m in 2024.
The Benelux region is increasingly prioritizing innovative diabetes care devices, reflecting a growing emphasis on patient-centered healthcare solutions and technological advancements.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in Benelux is witnessing considerable growth, fueled by factors such as the rising prevalence of diabetes, increased health awareness, advancements in technology, and the demand for more efficient self-monitoring solutions.

Customer preferences: In the Benelux region, consumers are prioritizing personalized diabetes care solutions that cater to their unique lifestyles and preferences. There is a growing inclination towards smart glucose monitoring devices that integrate seamlessly with mobile applications, allowing for real-time data tracking and analytics. Additionally, as awareness of diabetes management rises, individuals are increasingly favoring educational resources and community support networks that provide guidance on diet and exercise. This shift reflects a broader trend towards holistic health management that emphasizes both technology and lifestyle adaptation.

Trends in the market: In the Benelux region, the Diabetes Care Devices Market is increasingly centered on advanced digital solutions, with a notable rise in the adoption of continuous glucose monitoring (CGM) systems. These devices not only provide real-time glucose data but also connect with health apps for tailored insights, enhancing patient engagement. Moreover, there is a heightened focus on patient education and community involvement, as people seek resources that empower them to manage diabetes proactively. This trend signifies a shift towards integrated health solutions, presenting opportunities for manufacturers and healthcare providers to innovate and collaborate in delivering comprehensive diabetes management programs.

Local special circumstances: In the Benelux region, the Diabetes Care Devices Market is shaped by a combination of high healthcare standards and a strong emphasis on patient-centric care. The countries' robust healthcare infrastructure facilitates the integration of advanced digital solutions, enabling seamless data sharing between patients and providers. Cultural attitudes toward health encourage proactive diabetes management, while stringent regulatory frameworks ensure the safety and efficacy of devices. Additionally, the region's focus on sustainability drives demand for eco-friendly products, influencing manufacturers to innovate in both technology and materials.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the Benelux region is significantly influenced by macroeconomic factors such as national economic stability, healthcare investment, and demographic trends. Strong economic performance in these countries supports increased healthcare spending, enabling healthcare providers to adopt advanced diabetes technologies. Additionally, favorable fiscal policies that encourage innovation and research in medical devices contribute to market growth. The rising prevalence of diabetes, coupled with an aging population, further drives demand for effective diabetes management solutions, making it essential for manufacturers to adapt to evolving patient needs and regulatory requirements.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.